Retatrutide
Retatrutide is a novel triple agonist peptide currently used in laboratory research. It simultaneously targets three key receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.
In preclinical and clinical research settings, Retatrutide has demonstrated significant effects on metabolic parameters, including substantial reductions in body weight, improved glucose regulation, and beneficial changes in lipid metabolism. Its unique triple-agonist mechanism makes it a valuable tool for scientists studying obesity, type 2 diabetes, and metabolic dysfunction.
Product Specifications:
• Sequence: Synthetic 39-amino acid peptide
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder
• Intended Use: For laboratory research use only
• Storage: -20°C for long-term stability
Important Notice: Retatrutide is sold strictly for non-human laboratory research. It is not for human consumption, therapeutic, or diagnostic use.
Bitcoin payment only!
No other payments are accepted at this time.
Continue through the checkout process. At the end you will be a btcPay address/QR code.
Once payment is completed you will receive confirmation within 1-2 minutes.

